FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Sarah Rose

Research Profile

Living Beings

Chemicals & Drugs

Anatomy

Disorders

Activities & Behaviors

Motor Activity

Concepts & Ideas

Co-author Network

Publications

TOP 3
Philip Long; Peter Jenner; Parwez Samnakay; Sarah Rose
A yeast two-hybrid screen reveals that osteopontin associates with MAP1A and MAP1B in addition to other proteins linked to microtubule stability, apoptosis and protein degradation in the human brain.
Kayhan A Tayarani-Binazir; Michael J Jackson; Mark Jairaj; Sarah Rose; Isobel Strang; Peter Jenner
Benserazide dosing regimen affects the response to L-3,4-dihydroxyphenylalanine in the 6-hydroxydopamine-lesioned rat.
mahmoud iravani; Peter Jenner; Clement C M Leung; Mona Sadeghian; Sarah Rose
Lipopolysaccharide-induced nigral inflammation leads to increased IL-1β tissue content and expression of astrocytic glial cell line-derived neurotrophic factor.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Sarah Rose (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Philip Long; Peter Jenner; Parwez Samnakay; Sarah Rose
A yeast two-hybrid screen reveals that osteopontin associates with MAP1A and MAP1B in addition to other proteins linked to microtubule stability, apoptosis and protein degradation in the human brain.
The European journal of neuroscience 2012;36(6):2733-42.
2012: Kayhan A Tayarani-Binazir; Michael J Jackson; Mark Jairaj; Sarah Rose; Isobel Strang; Peter Jenner
Benserazide dosing regimen affects the response to L-3,4-dihydroxyphenylalanine in the 6-hydroxydopamine-lesioned rat.
Behavioural pharmacology 2012;23(2):126-33.
2012: mahmoud iravani; Peter Jenner; Clement C M Leung; Mona Sadeghian; Sarah Rose
Lipopolysaccharide-induced nigral inflammation leads to increased IL-1β tissue content and expression of astrocytic glial cell line-derived neurotrophic factor.
Neuroscience letters 2012;510(2):138-42.
2011: Monika J Brzozowski; Mahmoud M Iravani; Susana Lopez Alcantara; Sarah Rose; Peter Jenner
The effect of nNOS inhibitors on toxin-induced cell death in dopaminergic cell lines depends on the extent of enzyme expression.
Brain research 2011;1404():21-30.
2011: Matthew J Hansard; Michael J Jackson; Lance A Smith; Sarah Rose; Peter Jenner
A major metabolite of bupropion reverses motor deficits in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated common marmosets.
Behavioural pharmacology 2011;22(3):269-74.
2010: Kayhan Tayarani-Binazir; Michael J Jackson; Sarah Rose; A C McCreary; Peter Jenner
The partial dopamine agonist pardoprunox (SLV308) administered in combination with l-dopa improves efficacy and decreases dyskinesia in MPTP treated common marmosets.
Experimental neurology 2010;226(2):320-7.
2010: Bai-Yun Zeng; mahmoud iravani; Michael J Jackson; Sarah Rose; André Parent; Peter Jenner
Morphological changes in serotoninergic neurites in the striatum and globus pallidus in levodopa primed MPTP treated common marmosets with dyskinesia.
Neurobiology of disease 2010;40(3):599-607.
2010: Louisa C Johnston; Michael John Jackson; Sarah Rose; Andrew Christopher McCreary; Peter Jenner
Pardoprunox reverses motor deficits but induces only mild dyskinesia in MPTP-treated common marmosets.
Movement disorders : official journal of the Movement Disorder Society 2010;25(13):2059-66.
2010: Joanna Iczkiewicz; Lauren Broom; Jonathan D Cooper; Andrew Ming Sham Wong; Sarah Rose; Peter Jenner
The RGD-containing peptide fragment of osteopontin protects tyrosine hydroxylase positive cells against toxic insult in primary ventral mesencephalic cultures and in the rat substantia nigra.
Journal of neurochemistry 2010;114(6):1792-804.
2010: Kayhan Tayarani-Binazir; Michael J Jackson; Ria Fisher; Ghada Zoubiane; Sarah Rose; Peter Jenner
The timing of administration, dose dependence and efficacy of dopa decarboxylase inhibitors on the reversal of motor disability produced by L-DOPA in the MPTP-treated common marmoset.
European journal of pharmacology 2010;635(1-3):109-16.
2010: Salma Bukhatwa; Bai-Yun Zeng; Sarah Rose; Peter Jenner
A comparison of changes in proteasomal subunit expression in the substantia nigra in Parkinson's disease, multiple system atrophy and progressive supranuclear palsy.
Brain research 2010;1326():174-83.
2010: Kayhan Tayarani-Binazir; Michael J Jackson; Sarah Rose; C Warren Olanow; Peter Jenner
Pramipexole combined with levodopa improves motor function but reduces dyskinesia in MPTP-treated common marmosets.
Movement disorders : official journal of the Movement Disorder Society 2010;25(3):377-84.
2010: K A Stockwell; D K A Scheller; Lance A Smith; Sarah Rose; mahmoud iravani; Michael J Jackson; Peter Jenner
Continuous rotigotine administration reduces dyskinesia resulting from pulsatile treatment with rotigotine or L-DOPA in MPTP-treated common marmosets.
Experimental neurology 2010;221(1):79-85.
2010: Bai-Yun Zeng; Robert H Balfour; Mike J Jackson; Sarah Rose; Peter Jenner
Expression of catechol-O-methyltransferase in the brain and periphery of normal and MPTP-treated common marmosets.
Journal of neural transmission (Vienna, Austria : 1996) 2010;117(1):45-51.
2009: K A Stockwell; D Scheller; Sarah Rose; Michael J Jackson; Kayhan Tayarani-Binazir; mahmoud iravani; Lance A Smith; C Warren Olanow; Peter Jenner
Continuous administration of rotigotine to MPTP-treated common marmosets enhances anti-parkinsonian activity and reduces dyskinesia induction.
Experimental neurology 2009;219(2):533-42.
2009: Salma Bukhatwa; mahmoud iravani; Bai-Yun Zeng; Jonathan D Cooper; Sarah Rose; Peter Jenner
An immunohistochemical and stereological analysis of PSI-induced nigral neuronal degeneration in the rat.
Journal of neurochemistry 2009;109(1):52-9.
2008: mahmoud iravani; Mona Sadeghian; Clement C M Leung; Banu C Tel; Sarah Rose; Anthony H V Schapira; Peter Jenner
Continuous subcutaneous infusion of pramipexole protects against lipopolysaccharide-induced dopaminergic cell death without affecting the inflammatory response.
Experimental neurology 2008;212(2):522-31.
2008: K A Stockwell; David J Virley; M Perren; mahmoud iravani; Michael J Jackson; Sarah Rose; Peter Jenner
Continuous delivery of ropinirole reverses motor deficits without dyskinesia induction in MPTP-treated common marmosets.
Experimental neurology 2008;211(1):172-9.
2007: Mohammed Zubair; Michael J Jackson; Kayhan Tayarani-Binazir; Kim A Stockwell; Lance A Smith; Sarah Rose; Warren Olanow; Peter Jenner
The administration of entacapone prevents L-dopa-induced dyskinesia when added to dopamine agonist therapy in MPTP-treated primates.
Experimental neurology 2007;208(2):177-84.
2007: Joanna Iczkiewicz; Sarah Rose; Peter Jenner
Osteopontin expression in activated glial cells following mechanical- or toxin-induced nigral dopaminergic cell loss.
Experimental neurology 2007;207(1):95-106.
2007: Sarah Rose; Dieter K A Scheller; Alexander Breidenbach; Lance Smith; Michael Jackson; Kim Stockwell; Peter Jenner
Plasma levels of rotigotine and the reversal of motor deficits in MPTP-treated primates.
Behavioural pharmacology 2007;18(2):155-60.
2007: Michael J Jackson; Lance A Smith; Ghassan Al-Barghouthy; Sarah Rose; Peter Jenner
Decreased expression of l-dopa-induced dyskinesia by switching to ropinirole in MPTP-treated common marmosets.
Experimental neurology 2007;204(1):162-70.
2006: Joanna Iczkiewicz; Michael J Jackson; Lance A Smith; Sarah Rose; Peter Jenner
Osteopontin expression in substantia nigra in MPTP-treated primates and in Parkinson's disease.
Brain research 2006;1118(1):239-50.
2006: Bai-Yun Zeng; Salma Bukhatwa; Atsuko Hikima; Sarah Rose; Peter Jenner
Reproducible nigral cell loss after systemic proteasomal inhibitor administration to rats.
Annals of neurology 2006;60(2):248-52.
2006: Lance A Smith; Michael J Jackson; Louisa Johnston; Mikko Kuoppamaki; Sarah Rose; Ghassan Al-Barghouthy; Susanna Del Signore; Peter Jenner
Switching from levodopa to the long-acting dopamine D2/D3 agonist piribedil reduces the expression of dyskinesia while maintaining effective motor activity in MPTP-treated primates.
Clinical neuropharmacology 2006;29(3):112-25.
2006: Bai-Yun Zeng; mahmoud iravani; S-T Lin; M Irifune; Mikko Kuoppamäki; Ghassan Al-Barghouthy; Lance Smith; Michael J Jackson; Sarah Rose; Andrew D Medhurst; Peter Jenner
MPTP treatment of common marmosets impairs proteasomal enzyme activity and decreases expression of structural and regulatory elements of the 26S proteasome.
The European journal of neuroscience 2006;23(7):1766-74.
2006: mahmoud iravani; Claire O Haddon; Sarah Rose; Peter Jenner
3-Nitrotyrosine-dependent dopaminergic neurotoxicity following direct nigral administration of a peroxynitrite but not a nitric oxide donor.
Brain research 2006;1067(1):256-62.
2005: Manal M Abd El Mohsen; mahmoud iravani; Jeremy P E Spencer; Sarah Rose; Atef T Fahim; Tarek M K Motawi; Nabila A F Ismail; Peter Jenner
Age-associated changes in protein oxidation and proteasome activities in rat brain: modulation by antioxidants.
Biochemical and biophysical research communications 2005;336(2):386-91.
2005: mahmoud iravani; Clement C M Leung; Mona Sadeghian; Claire O Haddon; Sarah Rose; Peter Jenner
The acute and the long-term effects of nigral lipopolysaccharide administration on dopaminergic dysfunction and glial cell activation.
The European journal of neuroscience 2005;22(2):317-30.
2005: Bai-Yun Zeng; Andrew D Medhurst; M Jackson; Sarah Rose; Peter Jenner
Proteasomal activity in brain differs between species and brain regions and changes with age.
Mechanisms of ageing and development 2005;126(6-7):760-6.
2005: Joanna Iczkiewicz; Sarah Rose; Peter Jenner
Increased osteopontin expression following intranigral lipopolysaccharide injection in the rat.
The European journal of neuroscience 2005;21(7):1911-20.
2005: Lance A Smith; Michael J Jackson; Ghassan Al-Barghouthy; Sarah Rose; Mikko Kuoppamaki; Warren Olanow; Peter Jenner
Multiple small doses of levodopa plus entacapone produce continuous dopaminergic stimulation and reduce dyskinesia induction in MPTP-treated drug-naive primates.
Movement disorders : official journal of the Movement Disorder Society 2005;20(3):306-14.
2004: mahmoud iravani; Lin Liu; Sarah Rose; Peter Jenner
Role of inducible nitric oxide synthase in N-methyl-d-aspartic acid-induced strio-nigral degeneration.
Brain research 2004;1029(1):103-13.
2004: Joanna Iczkiewicz; Sarah Rose; Peter Jenner
Osteopontin (Eta-1) is present in the rat basal ganglia.
Brain research. Molecular brain research 2004;132(1):64-72.
2004: Bai-Yun Zeng; Simon J R Heales; Laura Canevari; Sarah Rose; Peter Jenner
Alterations in expression of dopamine receptors and neuropeptides in the striatum of GTP cyclohydrolase-deficient mice.
Experimental neurology 2004;190(2):515-24.
2003: E A Gilbert; R J Edwards; A R Boobis; Sarah Rose; Peter Jenner
Differential expression of cytochrome P450 enzymes in cultured and intact foetal rat ventral mesencephalon.
Journal of neural transmission (Vienna, Austria : 1996) 2003;110(10):1091-101.
2003: M J Schwarz; Peter J Houghton; Sarah Rose; Peter Jenner; Andrew J Lees
Activities of extract and constituents of Banisteriopsis caapi relevant to parkinsonism.
Pharmacology, biochemistry, and behavior 2003;75(3):627-33.
2003: M T Silva; Sarah Rose; JG Hindmarsh; Peter Jenner
Inhibition of neuronal nitric oxide synthase increases dopamine efflux from rat striatum.
Journal of neural transmission (Vienna, Austria : 1996) 2003;110(4):353-62.
2003: S A Treseder; Sarah Rose; L Summo; Peter Jenner
Commonly used L-amino acid decarboxylase inhibitors block monoamine oxidase activity in the rat.
Journal of neural transmission (Vienna, Austria : 1996) 2003;110(3):229-38.
2003: Carla Cannizzaro; Banu C Tel; Sarah Rose; Bai-Yun Zeng; Peter Jenner
Increased neuropeptide Y mRNA expression in striatum in Parkinson's disease.
Brain research. Molecular brain research 2003;110(2):169-76.
2002: Manal M Abd El Mohsen; Gunter Georg Christian Kuhnle; Andreas R Rechner; Hagen Schroeter; Sarah Rose; Peter Jenner; Catherine A Rice-Evans
Uptake and metabolism of epicatechin and its access to the brain after oral ingestion.
Free radical biology & medicine 2002;33(12):1693-702.
2002: Lance A Smith; Banu C Tel; Michael J Jackson; Matthew J Hansard; Rogelio Braceras; Céline Bonhomme; Claire Chezaubernard; Susanna Del Signore; Sarah Rose; Peter Jenner
Repeated administration of piribedil induces less dyskinesia than L-dopa in MPTP-treated common marmosets: a behavioural and biochemical investigation.
Movement disorders : official journal of the Movement Disorder Society 2002;17(5):887-901.
2002: Bai-Yun Zeng; B Dass; A Owen; Sarah Rose; Carla Cannizzaro; Banu C Tel; Peter Jenner
6-Hydroxydopamine lesioning differentially affects alpha-synuclein mRNA expression in the nucleus accumbens, striatum and substantia nigra of adult rats.
Neuroscience letters 2002;322(1):33-6.
2002: Banu C Tel; Bai-Yun Zeng; Carla Cannizzaro; R K B Pearce; Sarah Rose; Peter Jenner
Alterations in striatal neuropeptide mRNA produced by repeated administration of L-DOPA, ropinirole or bromocriptine correlate with dyskinesia induction in MPTP-treated common marmosets.
Neuroscience 2002;115(4):1047-58.
2001: Boris Ferger; Claudia Themann; Sarah Rose; Barry Halliwell; Peter Jenner
6-hydroxydopamine increases the hydroxylation and nitration of phenylalanine in vivo: implication of peroxynitrite formation.
Journal of neurochemistry 2001;78(3):509-14.
2001: Boris Ferger; Sarah Rose; Andrew M Jenner; Barry Halliwell; Peter Jenner
6-hydroxydopamine increases hydroxyl free radical production and DNA damage in rat striatum.
Neuroreport 2001;12(6):1155-9.
1999: Bai-Yun Zeng; B Dass; A Owen; Sarah Rose; Carla Cannizzaro; Banu C Tel; Peter Jenner
Chronic L-DOPA treatment increases striatal cannabinoid CB1 receptor mRNA expression in 6-hydroxydopamine-lesioned rats.
Neuroscience letters 1999;276(2):71-4.
1999: Sarah Rose; JG Hindmarsh; Peter Jenner
Neuronal nitric oxide synthase inhibition reduces MPP+-evoked hydroxyl radical formation but not dopamine efflux in rat striatum.
Journal of neural transmission (Vienna, Austria : 1996) 1999;106(5-6):477-86.
1998: M T Silva; Sarah Rose; JG Hindmarsh; Peter Jenner; CD Marsden
L-arginine produces NO-independent increases in dopamine efflux in rat striatum.
Neuroreport 1998;9(1):149-52.
1997: Sarah Rose; JG Hindmarsh; P Collins; Peter Jenner
The effect of fenfluramine dosage regimen and reduced food intake on levels of 5-HT in rat brain.
Journal of neural transmission (Vienna, Austria : 1996) 1997;104(11-12):1339-51.
1996: Sarah Rose; S Hunt; P Collins; JG Hindmarsh; Peter Jenner
Repeated administration of escalating high doses of dexfenfluramine does not produce morphological evidence for neurotoxicity in the cortex of rats.
Neurodegeneration : a journal for neurodegenerative disorders, neuroprotection, and neuroregeneration 1996;5(2):145-52.
1995: M T Silva; Sarah Rose; JG Hindmarsh; G Aislaitner; J W Gorrod; PK Moore; Peter Jenner; CD Marsden
Increased striatal dopamine efflux in vivo following inhibition of cerebral nitric oxide synthase by the novel monosodium salt of 7-nitro indazole.
British journal of pharmacology 1995;114(2):257-8.
1994: G M MacKenzie; Sarah Rose; P A Bland-Ward; PK Moore; Peter Jenner; CD Marsden
Time course of inhibition of brain nitric oxide synthase by 7-nitro indazole.
Neuroreport 1994;5(15):1993-6.
1994: Sarah Rose; JG Hindmarsh; M J Steiger; M Bhatt; Niall Quinn; Peter Jenner; CD Marsden
Plasma HVA levels following debrisoquine administration do not reflect cerebral dopamine loss in early Parkinson's disease.
Clinical neuropharmacology 1994;17(3):260-9.
1994: Sarah Rose; Peter Jenner; CD Marsden
Chronic administration does not alter the accumulation of L-dopa into muscle.
Movement disorders : official journal of the Movement Disorder Society 1994;9(2):167-72.
1994: David T Dexter; jeswinder sian; Sarah Rose; JG Hindmarsh; V M Mann; J Mark Cooper; F R Wells; Susan E Daniel; Andrew J Lees; Anthony H V Schapira
Indices of oxidative stress and mitochondrial function in individuals with incidental Lewy body disease.
Annals of neurology 1994;35(1):38-44.
1993: Sarah Rose; Peter Jenner; CD Marsden
Chronic administration does not alter the pharmacokinetic profile of L-dopa in the rat.
The Journal of pharmacy and pharmacology 1993;45(8):725-30.
1993: Sarah Rose; M Nomoto; E A Jackson; W R Gibb; P Jaehnig; Peter Jenner; CD Marsden
Age-related effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment of common marmosets.
European journal of pharmacology 1993;230(2):177-85.
1992: M D Taylor; M L De Ceballos; Sarah Rose; Peter Jenner; CD Marsden
Effects of a unilateral 6-hydroxydopamine lesion and prolonged L-3,4-dihydroxyphenylalanine treatment on peptidergic systems in rat basal ganglia.
European journal of pharmacology 1992;219(2):183-92.
1992: K L Thomas; Sarah Rose; Peter Jenner; CD Marsden
Acute reserpine treatment induces down regulation of D-1 dopamine receptor associated adenylyl cyclase activity in rat striatum.
Biochemical pharmacology 1992;44(1):83-91.
1992: K L Thomas; Sarah Rose; Peter Jenner; CD Marsden
Dissociation of the striatal D-2 dopamine receptor from adenylyl cyclase following 6-hydroxydopamine-induced denervation.
Biochemical pharmacology 1992;44(1):73-82.
1991: Sarah Rose; Peter Jenner; CD Marsden
Peripheral pharmacokinetic handling and metabolism of L-dopa in the rat: the effect of route of administration and carbidopa pretreatment.
The Journal of pharmacy and pharmacology 1991;43(5):325-30.
1991: M D Taylor; M L de Ceballos; Sarah Rose; P N Chong; Peter Jenner; CD Marsden
Neuropeptide levels in the basal ganglia of aged common marmosets following prolonged treatment with MPTP.
Journal of neural transmission. Parkinson's disease and dementia section 1991;3(2):99-108.
1990: Sarah Rose; M Nomoto; E A Jackson; W R Gibb; Peter Jenner; CD Marsden
1-Methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine (2'-methyl-MPTP) is less neurotoxic than MPTP in the common marmoset.
European journal of pharmacology 1990;181(1-2):97-103.
1989: Sarah Rose; M Nomoto; E A Jackson; W R Gibb; Peter Jenner; CD Marsden
Treatment with a selective MAO B inhibitor prevents loss of dopamine in the nucleus accumbens of MPTP-treated common marmosets.
Neuropharmacology 1989;28(11):1211-6.
1989: Sarah Rose; M Nomoto; E Kelly; G Kilpatrick; Peter Jenner; CD Marsden
Increased caudate dopamine turnover may contribute to the recovery of motor function in marmosets treated with the dopaminergic neurotoxin MPTP.
Neuroscience letters 1989;101(3):305-10.